BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10335037)

  • 1. [Chemotherapy of malignant melanoma].
    Jedrzejczak WW
    Pol Arch Med Wewn; 1998 Oct; 100(4):294-9. PubMed ID: 10335037
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic chemotherapy in the treatment of malignant melanoma.
    Lens MB; Eisen TG
    Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha.
    Vuoristo M; Gröhn P; Kumpulainen E; Korpela M
    Eur J Cancer; 1994; 30A(3):420. PubMed ID: 7515632
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
    Vuoristo MS; Hahka-Kemppinen M; Parvinen LM; Pyrhönen S; Seppä H; Korpela M; Kellokumpu-Lehtinen P
    Melanoma Res; 2005 Aug; 15(4):291-6. PubMed ID: 16034308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
    Punt CJ; van Herpen CM; Jansen RL; Vreugdenhil G; Muller EW; de Mulder PH
    Br J Cancer; 1997; 76(2):266-9. PubMed ID: 9231931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial Sepsis Increases Survival in Metastatic Melanoma: Chlamydophila Pneumoniae Induces Macrophage Polarization and Tumor Regression.
    Buzás K; Marton A; Vizler C; Gyukity-Sebestyén E; Harmati M; Nagy K; Zvara Á; Katona RL; Tubak V; Endrész V; Németh IB; Oláh J; Vígh L; Bíró T; Kemény L
    J Invest Dermatol; 2016 Apr; 136(4):862-865. PubMed ID: 26743601
    [No Abstract]   [Full Text] [Related]  

  • 7. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
    Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
    Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Ambinder EP; Holland JF
    Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemotherapy for advanced melanoma: maybe it is real.
    Khayat D; Bernard-Marty C; Meric JB; Rixe O
    J Clin Oncol; 2002 May; 20(10):2411-4. PubMed ID: 12011117
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.
    Everall JD; Dowd PM
    Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of malignant melanoma].
    Avril MF
    Ann Dermatol Venereol; 1988; 115(9):959-68. PubMed ID: 2464963
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant chemotherapy of malignant melanoma. A pilot study.
    Hansson J; Ringborg U; Lagerlöf B; Strander H
    Am J Clin Oncol; 1985 Feb; 8(1):47-50. PubMed ID: 3993625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What can we learn from phase II adjuvant trials in melanoma?
    Keilholz U; Suciu S; Eggermont AM
    Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
    [No Abstract]   [Full Text] [Related]  

  • 15. Three-drug combination of cisplatin, dacarbazine, and tamoxifen in metastatic malignant melanoma.
    Chmielowska E; Potemski P; Pluzańska A
    J Clin Oncol; 1995 Aug; 13(8):2146-7. PubMed ID: 7636562
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report.
    Fukunaga T; Soejima H; Sugamura K; Kojima S; Sugiyama S; Sakamoto T; Yoshimura M; Tanoue T; Kageshita T; Ono T; Ogawa H
    J Cardiol; 2006 Apr; 47(4):191-5. PubMed ID: 16637253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single drug and combination chemotherapy in the treatment. Disseminated malignant melanoma.
    Aranha GV; Grage TB
    Minn Med; 1977 Aug; 60(8):543-8. PubMed ID: 882082
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
    Del Prete SA; Maurer LH; O'Donnell J; Forcier RJ; LeMarbre P
    Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
    Cancer; 1989 May; 63(9):1676-80. PubMed ID: 2467736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.